L-dopa level in plasma, primary condition for the kinetic effect.
Birkmayer, W
L-dopa level in plasma, primary condition for the kinetic effect. [electronic resource] - Journal of neural transmission 1973 - 133-43 p. digital
Publication Type: Journal Article
10.1007/BF01244666 doi
Administration, Oral
Aged
Amantadine--administration & dosage
Aromatic Amino Acid Decarboxylase Inhibitors
Biopharmaceutics
Brain--metabolism
Dihydroxyphenylalanine--administration & dosage
Drug Synergism
Evaluation Studies as Topic
Female
Humans
Hydrazines--administration & dosage
Injections, Intravenous
Male
Motor Activity--drug effects
Parkinson Disease--blood
L-dopa level in plasma, primary condition for the kinetic effect. [electronic resource] - Journal of neural transmission 1973 - 133-43 p. digital
Publication Type: Journal Article
10.1007/BF01244666 doi
Administration, Oral
Aged
Amantadine--administration & dosage
Aromatic Amino Acid Decarboxylase Inhibitors
Biopharmaceutics
Brain--metabolism
Dihydroxyphenylalanine--administration & dosage
Drug Synergism
Evaluation Studies as Topic
Female
Humans
Hydrazines--administration & dosage
Injections, Intravenous
Male
Motor Activity--drug effects
Parkinson Disease--blood